Different Approaches for the Management of Post-dural Puncture Headache

Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post-Dural Puncture Headache Brain Diseases Central Nervous System Diseases Headache Disorders Headache Disorders, Secondary Nervous System Diseases

Age range

20 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Sohag faculty of medicine

Sohag, 82524, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The ASA physical condition І-П
the patient underwent CS under spinal anesthesia
The headache developed within 5 days after the dural puncture
There is no different explanation for the headache

Exclusion criteria

coagulopathy
history of nasal bleeding
nasal polyp
septal deviation
local anesthetics reaction

Treatment and study plan

Sphenopalatine Ganglion Block

Procedure

block of the sphenopalatine ganglion using either lidocaine or bupivacaine to relief postdural puncture headache

Paracetamol

Drug

intravenous paracetamol every 8 hours

Primary outcomes

postdural puncture headache

Time frame: within five days after the dural puncture

visual analog scale

Sponsors and collaborators

Lead sponsor

Bahaa Mohammed Refaie

Other

Registry information

Official study title

Comparative Study Between Different Approaches for the Management of Post-dural Puncture Headache

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Feb 23, 2022
Registry last updated: Feb 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed